Serametrix Corp. - A Caprion Biosciences Company
Biotechnology ResearchCalifornia, United States11-50 Employees
LATEST NEWS: Caprion and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development More info: https://bit.ly/2yFAxnb Caprion Biosciences Acquires Serametrix Corporation More info: https://bit.ly/2IQNCkV Serametrix provides solutions to the problem of measuring immune responses to immunotherapies. Our services enable the analysis of biomarkers involved in the immune response that are associated with both drug response and disease progression. Serametrix scientists utilise and customize various immune monitoring techniques within our global accredited facilities in the Americas, Europe and China to quickly and efficiently launch assays for the newest biomarkers in today’s field of immunoscience. We standardize and provide access to proven technologies from trusted leaders including autoimmune and inflammation with a speciality in immuno-oncology. As a commercial entity we excel in combining scientific and technical expertise with practical deliverability to develop and validate customisable biomarker assays across immune monitoring technologies. Some of these technologies include flow cytometry, serum profiling and proprietary data analysis. With the ability to commercialise and operationalise our technology globally for large scale clinical trials; Serametrix are successfully contributing to moving the clinical development of new drugs and personalised medicine forward, faster and more efficiently.
1-888-653-2347 
support@leadiq.com 
